- Secured multiple invitations for clients to voluntarily appear before Congressional committees and counseled their testimony.
- Provided strategic counsel to a leading medical device trade association on Medicare reimbursement and coverage policies related to cutting edge technologies.
- Helped client navigate a committee oversight investigation on a priority issue to the industry.
- Facilitated inclusion of client priority legislative language into the FY22 omnibus funding bill.
- Developed and executed a strategy for a health care provider group seeking revisions to Medicare clinical regulations and provides ongoing technical expertise.
- Called on by committee staff and congressional caucuses to brief staff as a subject matter expert on Medicare reimbursement and payment policy.
- Drafted legislative language for bill introduction, amendment consideration, and comment letters.
- Led negotiations on and oversaw the implementation of all health-related provisions in five legislative vehicles responding to the COVID-19 pandemic.
- Negotiated the permanent repeal and replace of both Medicare’s sustainable growth rate formula and its outpatient therapy caps.
- Spearheaded successful congressional efforts to end surprise medical bills.
- Worked extensively on the FDA Safety and Innovation Act, 21st Century Cures Act, the Medicare Access and CHIP Reauthorization Act, the Bipartisan Budget Act of 2018, the Comprehensive Addiction and Recovery Act, and the SUPPORT Act.
James “JP” Paluskiewicz is a senior policy advisor in the Health Care group. JP advises health care clients on legislative and public policy matters before Congress, the Administration, and other government agencies. JP devises strategies for effective outreach and messaging to assist health care clients in navigating complex legislation and regulation. He develops and executes legislative and regulatory solutions on behalf of health care provider groups, health care systems, hospitals, biopharmaceutical and medical device companies, and health payers while working directly with policymakers on the Hill and in the Administration to secure their passage and implementation.
JP was chief counsel on the House Energy and Commerce Committee, Health Subcommittee and oversaw all policy matters under the committee’s jurisdiction, including legislation affecting the Food and Drug Administration, Medicare, Medicaid, private insurance, health information technology, and public health. He managed the committee’s health agenda, policy development, and legislative strategy for Republicans. He was also the sole policy staffer overseeing Medicare Parts B and D and health information technology. During his tenure on Capitol Hill, JP developed and shepherded numerous policies throughout the legislative process.
JP is an adjunct professor at The George Washington University’s Graduate School of Political Management and Milken Institute School of Public Health. JP regularly serves as a panelist and speaker on policy matters to health care audiences throughout the Washington, D.C. area.
-
Press Release December 12, 2024Navigating D.C. Power Shifts: Alston & Bird ResourcesSince the 2024 U.S. election, business executives, boards, and policy experts are moving quickly to understand and traverse changing economic and political dynamics. Global law firm Alston & Bird is uniquely positioned with extensive legal and policy expertise – with connections to the most influential players.Press Release December 12, 2024Navigating D.C. Power Shifts: Alston & Bird ResourcesSince the 2024 U.S. election, business executives, boards, and policy experts are moving quickly to understand and traverse changing economic and political dynamics. Global law firm Alston & Bird is uniquely positioned with extensive legal and policy expertise – with connections to the most influential players.
-
Advisories December 4, 2024Health Care Advisory: Potential Medicare Physician Fee Schedule Reform in the Last Weeks of the 118th CongressA flurry of bills to reform the Medicare Physician Fee Schedule (PFS) faces the lame duck Congress. Our Health Care Group investigates how those reforms could take shape and which, if any, could find their way through the legislative process.Advisories December 4, 2024Health Care Advisory: Potential Medicare Physician Fee Schedule Reform in the Last Weeks of the 118th CongressA flurry of bills to reform the Medicare Physician Fee Schedule (PFS) faces the lame duck Congress. Our Health Care Group investigates how those reforms could take shape and which, if any, could find their way through the legislative process.
-
Seminar October 10, 20242024 Pharmaceutical and Biologics SummitJoin us for an informative half-day program dedicated to hot topics in the pharmaceutical and biologics industry. Our attorneys will be joined by special guest speakers to provide a full spectrum look into both the legal and business opportunities of today's environment – and a glance at what to expect on the horizon.Seminar October 10, 20242024 Pharmaceutical and Biologics SummitJoin us for an informative half-day program dedicated to hot topics in the pharmaceutical and biologics industry. Our attorneys will be joined by special guest speakers to provide a full spectrum look into both the legal and business opportunities of today's environment – and a glance at what to expect on the horizon.
-
Advisories October 27, 2023Health Care Advisory: Is Medicare Physician Fee Schedule Reform on the Horizon?
The decreasing value of Medicare reimbursements for physicians has caught the attention of a group of doctors in Congress. Our Heath Care Group explains how draft legislation would stabilize the Physician Fee Schedule (PFS) before patients lose access to health care.
Advisories October 27, 2023Health Care Advisory: Is Medicare Physician Fee Schedule Reform on the Horizon?The decreasing value of Medicare reimbursements for physicians has caught the attention of a group of doctors in Congress. Our Heath Care Group explains how draft legislation would stabilize the Physician Fee Schedule (PFS) before patients lose access to health care.
-
Press Release July 10, 2023Alston & Bird Expands Health Policy Team with Senior Federation of American Hospitals OfficialAlston & Bird has expanded its bipartisan health policy practice with the addition of Jonathan Jagoda, former senior vice president of the Federation of American Hospitals (FAH). Jonathan joins the firm as senior policy advisor in the Washington, D.C. office.Press Release July 10, 2023Alston & Bird Expands Health Policy Team with Senior Federation of American Hospitals OfficialAlston & Bird has expanded its bipartisan health policy practice with the addition of Jonathan Jagoda, former senior vice president of the Federation of American Hospitals (FAH). Jonathan joins the firm as senior policy advisor in the Washington, D.C. office.
-
Speaking Engagement July 17–19, 2022Summer Conference and Annual MeetingJP Paluskiewicz will speak at this conference hosted by the ACCSES.Speaking Engagement July 17–19, 2022Summer Conference and Annual MeetingJP Paluskiewicz will speak at this conference hosted by the ACCSES.
-
Advisories June 14, 2022FDA/Food, Drug & Device / Health Care Legislative & Public Policy Advisory: Food and Drug Amendments of 2022 (PDUFA VII)Our FDA and Health Care Policy teams discuss how sponsors and manufacturers can prepare for legislative and regulatory changes that could come from the final Food and Drug Amendments (PDUFA VII) and what companies can do today to leverage their current capabilities for success.Advisories June 14, 2022FDA/Food, Drug & Device / Health Care Legislative & Public Policy Advisory: Food and Drug Amendments of 2022 (PDUFA VII)Our FDA and Health Care Policy teams discuss how sponsors and manufacturers can prepare for legislative and regulatory changes that could come from the final Food and Drug Amendments (PDUFA VII) and what companies can do today to leverage their current capabilities for success.
-
In the News May 10, 2022The Hill | Lobbying ContractsJames Paluskiewicz is noted for representing the American Ambulance Association.In the News May 10, 2022The Hill | Lobbying ContractsJames Paluskiewicz is noted for representing the American Ambulance Association.
-
Webinar March 22, 2022Alston & Bird 2022 Virtual Annual Alumni & Client CLEJoin us virtually for the 2022 Alston & Bird Annual Alumni & Client CLE for up-to-the-minute news on legal hot topics and trends around the world.Webinar March 22, 2022Alston & Bird 2022 Virtual Annual Alumni & Client CLEJoin us virtually for the 2022 Alston & Bird Annual Alumni & Client CLE for up-to-the-minute news on legal hot topics and trends around the world.
-
Press Release January 28, 2022Alston & Bird Adds Former FDA Associate Chief Counsel Alexandra Marzelli as Counsel in Washington, D.C.Alston & Bird has expanded its health care and life sciences regulatory and compliance capabilities with the addition of counsel Alexandra Marzelli, former associate chief counsel at the U.S. Food and Drug Administration (FDA). Based in the firm’s Washington, D.C. office, Marzelli joins Alston & Bird’s Health Care and FDA/Food, Drug & Device Groups, where she will advise clients on the FDA’s complex approval process and regulatory compliance for prescription and over-the-counter drugs, biologics, medical devices, food ingredients, and other products regulated by the agency.Press Release January 28, 2022Alston & Bird Adds Former FDA Associate Chief Counsel Alexandra Marzelli as Counsel in Washington, D.C.Alston & Bird has expanded its health care and life sciences regulatory and compliance capabilities with the addition of counsel Alexandra Marzelli, former associate chief counsel at the U.S. Food and Drug Administration (FDA). Based in the firm’s Washington, D.C. office, Marzelli joins Alston & Bird’s Health Care and FDA/Food, Drug & Device Groups, where she will advise clients on the FDA’s complex approval process and regulatory compliance for prescription and over-the-counter drugs, biologics, medical devices, food ingredients, and other products regulated by the agency.
學歷
- The George Washington University (M.A., 2006)
- American University (學士學位, 2002)